A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
Completed
Sanofi
Phase 3
2005-04-01
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes
who are not well controlled on 2 or more oral anti-diabetic agents
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
Completed
Pfizer
Phase 3
2005-04-01
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes
who are not well controlled on 2 or more oral anti-diabetic agents
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
Terminated
Pfizer
Phase 3
2002-06-01
This study is being done to find out the good and bad effects of inhaled insulin that is used
by oral inhalation, to adult males and females with type 2 diabetes mellitus. The other name
for this inhaled insulin is Exubera®.
This study included a 2-year comparative treatment period followed by a 6-month follow-up
period during which inhaled insulin-treated subjects were switched back to subcutaneous
short-acting insulin. After this follow-up period, all eligible subjects entered a
comparative extension period that was to last for 5 years. When the comparative portion of
the study was terminated, all subjects were requested to return for a final extension
follow-up month 3 visit.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
